393 related articles for article (PubMed ID: 16879035)
1. Protoporphyrin IX fluorescence photobleaching and the response of rat Barrett's esophagus following 5-aminolevulinic acid photodynamic therapy.
Boere IA; Robinson DJ; de Bruijn HS; Kluin J; Tilanus HW; Sterenborg HJ; de Bruin RW
Photochem Photobiol; 2006; 82(6):1638-44. PubMed ID: 16879035
[TBL] [Abstract][Full Text] [Related]
2. Monitoring in situ dosimetry and protoporphyrin IX fluorescence photobleaching in the normal rat esophagus during 5-aminolevulinic acid photodynamic therapy.
Boere IA; Robinson DJ; de Bruijn HS; van den Boogert J; Tilanus HW; Sterenborg HJ; de Bruin RW
Photochem Photobiol; 2003 Sep; 78(3):271-7. PubMed ID: 14556314
[TBL] [Abstract][Full Text] [Related]
3. Monitoring ALA-induced PpIX photodynamic therapy in the rat esophagus using fluorescence and reflectance spectroscopy.
Kruijt B; de Bruijn HS; van der Ploeg-van den Heuvel A; de Bruin RW; Sterenborg HJ; Amelink A; Robinson DJ
Photochem Photobiol; 2008; 84(6):1515-27. PubMed ID: 18557821
[TBL] [Abstract][Full Text] [Related]
4. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect.
Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM
Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268
[TBL] [Abstract][Full Text] [Related]
5. Fractionated illumination for oesophageal ALA-PDT: effect on blood flow and PpIX formation.
van den Boogert J; van Staveren HJ; de Bruin RW; Siersema PD; van Hillegersberg R
Lasers Med Sci; 2001; 16(1):16-25. PubMed ID: 11486333
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice.
Pech O; Nagy CD; Gossner L; May A; Ell C
Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):657-62. PubMed ID: 12072600
[TBL] [Abstract][Full Text] [Related]
7. 5-Aminolevulinic acid photosensitization of dysplastic Barrett's esophagus: a pharmacokinetic study.
Ackroyd R; Brown N; Vernon D; Roberts D; Stephenson T; Marcus S; Stoddard C; Reed M
Photochem Photobiol; 1999 Oct; 70(4):656-62. PubMed ID: 10546561
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect.
Robinson DJ; de Bruijn HS; van der Veen N; Stringer MR; Brown SB; Star WM
Photochem Photobiol; 1998 Jan; 67(1):140-9. PubMed ID: 9477772
[TBL] [Abstract][Full Text] [Related]
9. Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy.
Ascencio M; Collinet P; Farine MO; Mordon S
Lasers Surg Med; 2008 Jul; 40(5):332-41. PubMed ID: 18563777
[TBL] [Abstract][Full Text] [Related]
10. Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus.
Kelty CJ; Ackroyd R; Brown NJ; Brown SB; Reed MW
Surg Endosc; 2004 Mar; 18(3):452-8. PubMed ID: 14752635
[TBL] [Abstract][Full Text] [Related]
11. Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin.
Robinson DJ; de Bruijn HS; van der Veen N; Stringer MR; Brown SB; Star WM
Photochem Photobiol; 1999 Jan; 69(1):61-70. PubMed ID: 10063801
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia.
Tan WC; Fulljames C; Stone N; Dix AJ; Shepherd N; Roberts DJ; Brown SB; Krasner N; Barr H
J Photochem Photobiol B; 1999; 53(1-3):75-80. PubMed ID: 10672532
[TBL] [Abstract][Full Text] [Related]
13. A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen.
Liu B; Farrell TJ; Patterson MS
Phys Med Biol; 2010 Oct; 55(19):5913-32. PubMed ID: 20844331
[TBL] [Abstract][Full Text] [Related]
14. In situ light dosimetry during photodynamic therapy of Barrett's esophagus with 5-aminolevulinic acid.
van Veen RL; Aalders MC; Pasma KL; Siersema PD; Haringsma J; van de Vrie W; Gabeler EE; Robinson DJ; Sterenborg HJ
Lasers Surg Med; 2002; 31(5):299-304. PubMed ID: 12430146
[TBL] [Abstract][Full Text] [Related]
15. In vivo measurement of 5-aminolaevulinic acid-induced protoporphyrin IX photobleaching: a comparison of red and blue light of various intensities.
Nadeau V; O'Dwyer M; Hamdan K; Tait I; Padgett M
Photodermatol Photoimmunol Photomed; 2004 Aug; 20(4):170-4. PubMed ID: 15238094
[TBL] [Abstract][Full Text] [Related]
16. Photobleaching-based dosimetry predicts deposited dose in ALA-PpIX PDT of rodent esophagus.
Sheng C; Hoopes PJ; Hasan T; Pogue BW
Photochem Photobiol; 2007; 83(3):738-48. PubMed ID: 17576383
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus.
Claydon PE; Ackroyd R
Dis Esophagus; 2004; 17(3):205-12. PubMed ID: 15361092
[TBL] [Abstract][Full Text] [Related]
18. Protoporphyrin IX fluorescence and photobleaching during interstitial photodynamic therapy of malignant gliomas for early treatment prognosis.
Johansson A; Faber F; Kniebühler G; Stepp H; Sroka R; Egensperger R; Beyer W; Kreth FW
Lasers Surg Med; 2013 Apr; 45(4):225-34. PubMed ID: 23533060
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence photobleaching of ALA and ALA-heptyl ester induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: a comparison of two light sources and different illumination schemes.
Pudroma X; Juzeniene A; Ma LW; Iani V; Moan J
J Environ Pathol Toxicol Oncol; 2011; 30(3):235-40. PubMed ID: 22126616
[TBL] [Abstract][Full Text] [Related]
20. Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity.
van Den Boogert J; van Staveren HJ; de Bruin RWF ; de Rooij FWM ; Edixhoven-Bosdijk A; Siersema PD; van Hillegersberg R
J Photochem Photobiol B; 2000 Jun; 56(1):53-60. PubMed ID: 11073316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
